Evaluating the Dominus® Stent-Graft for treating thoracic aortic diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects real-world clinical data on the safety and efficacy of the Dominus® Stent-Graft Endoprosthesis in patients with thoracic aortic diseases. It involves a multicenter approach, enrolling 100 patients who will receive the stent-graft according to its Instructions for Use. The study aims to provide insights into the performance of the device in a post-market setting, with a focus on long-term follow-up and patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. 18 years of age or older;
2. Patients treated with the Dominus® Stent-Graft Endoprosthesis in accordance with its Instructions for Use;
3. Patient available for appropriate follow-up times for the study duration;
4. Informed patient about the nature of the study, agreeing to its provisions, and signing the informed consent.

Exclusion Criteria:

1. Patient currently participating in another clinical study of drug or medical device;
2. Life expectancy less than 12 months.

Where it's running

• Hospital Nossa Senhora da Conceição
  Porto Alegre, Rio Grande do Sul, Brazil Recruiting
• Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
  Ribeirão Preto, São Paulo, Brazil Recruiting
• Hospital Evangélico de Vila Velha
  Vila Velha, Espírito Santo, Brazil Not yet recruiting

Study contacts

• Principal investigator: Edwaldo Joviliano — Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
• Study coordinator: Glaucia Basso
• Email: glaucia.basso@braile.com.br
• Phone: +55 (17) 2136-7005

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• GORE MBA Arch Endoprosthesis Early Feasibility Study

  This study tests the safety of the MBA device in people with arch-related thoracic aortic diseases to see if it can be used safely in real-world settings.

  Recruiting at 3 sites W.L.Gore & Associates · Los Angeles, California and 2 other locations · NCT07564375

• Using presepsin levels to guide antibiotic treatment in thoracic aorta surgery patients

  This study is testing if measuring a specific marker in the blood can help doctors give the right antibiotics to patients after thoracic aorta surgery to prevent infections and improve recovery.

  Recruiting Petrovsky National Research Centre of Surgery · Moscow, Moscow · NCT06336213

• Endovascular treatment for aortic arch pathologies in Spain

  This study is testing if special stent devices can help people aged 18 to 90 with serious aortic arch problems live longer and stay safe.

  Recruiting Vascular Investigation Network Spanish Society for Angiology and Vascular Surgery · Madrid · NCT05309707

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.